Clinical Trial Update: Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and bioequivalence of estradiol vaginal inserts (10 mcg) with Vagifem (10 mcg) and placebo for vaginal atrophy due to menopause;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vaginal Atrophy

Drugs mentioned

• Estradiol vaginal insert 10 mcg (estradiol vaginal insert)
• Vagifem 10 mcg (estradiol vaginal insert)

Snippet

Sponsor: Amneal Pharmaceuticals, LLC | Conditions: Atrophic Vaginitis Due to Menopause | Phase 3 | Status: COMPLETED